(Q37777082)

English

Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third

scientific article published on January 1, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third (English)

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

1 reference

based on heuristic

inferred from title

author name string

Asad Kutup

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Emre F. Yekebas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20676876

14 June 2024

Jakob R. Izbicki

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20676876

14 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20676876

14 June 2024

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/978-3-540-70579-6_10

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Recent Results in Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

182

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

115-125

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma

1

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus

2

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Amplification and over-expression of theEGFR anderbB-2 genes in human esophageal adenocarcinomas

3

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

4

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement

8

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Is it time for a new TNM classification in esophageal carcinoma?

9

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries

10

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma

11

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

European Journal of Surgical Oncology

12

13

409

author name string

J Byrne

publication date

1987

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Lymph node mapping of esophageal cancer

14

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus

16

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

17

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3

18

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions

19

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus

20

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis

21

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance

23

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas

24

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer

25

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus

26

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States).

27

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues

28

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma

29

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma

30

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody Trastuzumab.

31

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions

33

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598.

34

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

35

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trastuzumab: hopes and realities

36

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer

37

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence

38

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma

39

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction

41

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.

42

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997.

43

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Dissecting the metastatic cascade

44

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow

45

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

International variation

46

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Cancer burden in the year 2000. The global picture

47

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer

48

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions

49

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction

50

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer

51

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer

52

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

The HER-2/neu oncogene in tumors of the gastrointestinal tract

53

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.

54

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.

55

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma

56

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

57

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus

58

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction

59

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Classification of adenocarcinoma of the oesophagogastric junction

60

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases

62

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression

67

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trends in esophageal cancer incidence by histology, United States, 1998-2003.

68

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction

69

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Trastuzumab trials steal show at ASCO meeting

70

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995

71

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett's adenocarcinoma.

72

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.

73

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus

74

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997

75

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma

76

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients

77

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

78

1 reference

10.1007/978-3-540-70579-6_10

https://api.crossref.org/works/10.1007/978-3-540-70579-6_10

14 June 2024

Identifiers

10.1007/978-3-540-70579-6_10

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37777082&oldid=2179516103"